Table 4.
Pair of regions | Coordinates x/y/z (mm) | Mean Z controls | Mean Z patients | P | d′ | |
---|---|---|---|---|---|---|
Enhanced negative STN‐coupling in PD patients | L+R STN–L IPS/SPC/S1 | −40/−48/56 | 0.019 | −0.143 | 0.0001 | −0.77 |
L+R STN–R SPC | 24/−64/62 | 0.008 | −0.127 | 0.0003 | −0.72 | |
L+R STN–R S1 | 34/−38/64 | 0.005 | −0.144 | 0.0001 | −0.78 | |
L+R STN–R IPS/SPC/S1 | 34/−48/50 | 0.012 | −0.142 | 0.0001 | −0.76 | |
L+R STN–L V1/V2 | −4/−94/14 | −0.004 | −0.116 | 0.0011 | −0.64 | |
Attenuated negative STN‐coupling in PD patients | L+R STN–R Crus I | 28/−76/−36 | −0.113 | 0.007 | 0.0004 | 0.69 |
L+R STN–R mid orbital/rectal gyrus | 8/58/−10 | −0.116 | −0.013 | 0.0015 | 0.63 |
Mean Z controls and Z patients denote group‐averaged functional connectivity in 55 healthy participants and 54 patients with Parkinsons's disease (PD); d' denotes the effect size according to Cohen's definition [Cohen, 1988]. STN, subthalamic nucleus; SPC, superior parietal cortex; S1, primary sensory cortex; IPS, intraparietal sulcus; V1 and V2, subregions (area 17 and 18) of the visual cortex; L, left; R, right; Crus I is part of cerebellar lobule VIIa.